Clinical Trial Update: A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced well-differentiated or dedifferentiated liposarcoma. The cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Liposarcoma, Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN